Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma. [electronic resource]
Producer: 20101207Description: 237-42 p. digitalISSN:- 1573-7373
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Brain Neoplasms -- drug therapy
- Camptothecin -- administration & dosage
- Female
- Follow-Up Studies
- Glioma -- drug therapy
- Humans
- Irinotecan
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Neoplasm Staging
- Retrospective Studies
- Survival Rate
- Treatment Outcome
- Withholding Treatment
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.